TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharmbiotech Oy
Closing information (x1000 NOK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
18,173
|
449
|
0 |
| Financial expenses |
143
|
0 | |
| Earnings before taxes |
5,125
|
1,797
|
-45 |
| Total assets |
6,915
|
24,939
|
21,834 |
| Current assets |
3,344
|
3,757
|
18,033 |
| Current liabilities |
18
|
19,367
|
18,133 |
| Equity capital |
73
|
163
|
81 |
| - share capital |
27
|
29
|
27 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
1.1%
|
0.7%
|
0.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
28.2%
|
400.2% | |
| Return on assets (ROA) |
7.8%
|
-0.2% | |
| Current ratio |
18577.8%
|
19.4%
|
99.4% |
| Return on equity (ROE) |
7020.5%
|
1102.5%
|
-55.6% |
| Change turnover |
17,746
|
449 | |
| Change turnover % | 4155% | ||
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.